Meda has today published its annual report for 2015 on www.meda.se. The printed version will be distributed to shareholders later in April.
For further inquiries, please contact:
Meda AB discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on March 24, 2016, at 10:00 CET.
MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit www.meda.se.